|
PIK3R2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
2.40410003016223E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
6.371600E-01 |
| Stage1-vs-Stage3 |
7.402400E-01 |
| Stage1-vs-Stage4 |
6.381500E-02 |
| Stage2-vs-Stage3 |
8.397800E-01 |
| Stage2-vs-Stage4 |
1.177420E-01 |
| Stage3-vs-Stage4 |
8.669600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.68200000278441E-08 |
| Normal-vs-Asian |
1.62547753035369E-12 |
| Caucasian-vs-AfricanAmerican |
9.852000E-01 |
| Caucasian-vs-Asian |
2.286600E-01 |
| AfricanAmerican-vs-Asian |
4.197600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
7.743800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.501580E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.418600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.607450E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.904600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.602000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.813400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.845800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.508000E-01 |
| Classical-VS-Follicular |
4.89410000004131E-06 |
| Classical-VS-Other |
9.992200E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
2.380100E-03 |
| Tall-VS-Other |
7.844400E-01 |
| Tall-VS-Normal |
1.85730320012567E-11 |
| Follicular-VS-Other |
1.528410E-01 |
| Follicular-VS-Normal |
5.44289999737657E-08 |
| Other-VS-Normal |
1.42220000221016E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
4.66293670342566E-15 |
| N0-vs-N1 |
3.202800E-01 |
|
|
